Medical
Pharmaceutical
Health

Therapix Biosciences

$3.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.10 (47.83%) Today
+$0.10 (2.94%) As of 5:40 PM EDT after-hours

Why Robinhood?

You can buy or sell TRPX and other stocks, options, ETFs, and crypto commission-free!

About TRPX

Therapix Biosciences Ltd. American Depositary Shares, also called Therapix Biosciences, is a specialty clinical-stage pharmaceutical company, focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. Read More It initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and BrainBright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. The company was founded on August 23, 2004 and is headquartered in Givatayim, Israel.

Employees
11
Headquarters
Givatayim, Tel Aviv
Founded
2004
Market Cap
8.06M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
70.77K
High Today
$4.69
Low Today
$3.05
Open Price
$3.65
Volume
2.90M
52 Week High
$9.30
52 Week Low
$2.22

Collections

Medical
Pharmaceutical
Health
Biotechnology
Technology
2017 IPO
US
North America

TRPX Earnings

-$0.59
-$0.51
-$0.43
-$0.35
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 20, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.